Replies to post #11252 on Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

This is one of your better posts. I don't see them turning profitable until Q2 of next year. However, I'm more worried about additional dilution. Their total expenses are still way to high based on their profit and amount of cash on hand.

[Biotech Pharmer]

Bullshit. Not even close. He is full of shit with that claim, just like FlutiCare, guidance, etc. He over promises and under delivers, and saps like you slurp it up.